Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Statins Before Cardiac Surgery: Substantial Benefit
Link ID 6224
Title Statins Before Cardiac Surgery: Substantial Benefit
Url http://www.medscape.com/viewarticle/575321?src=rss
Description Patients who received statins before cardiac surgery obtained reductions in short-term mortality, stroke, and atrial fibrillation, according to the largest meta-analysis to date on the subject. Medscape Medical News
Category Articles > Cardiology
Keywords
Date May 31, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Cardiology
1. Metformin Top Oral Antidiabetic for CV-Risk Reduction, Says Meta-Analysis
  The widely prescribed metformin was alone among oral antidiabetic agents to show a significant effect on cardiovascular risk in a meta-analysis of 40 select controlled trials. Medscape Medical News
Category:   Articles > Cardiology


2. FDA Safety Changes: Diovan HCT, Primaquine, Lopressor/Lopressor HCT
  The FDA has approved revisions to the safety labeling for valsartan plus hydrochlorothiazide tablets (Diovan HCT), primaquine phosphate tablets, and metoprolol tartrate (Lopressor and Lopressor HCT). Medscape Medical News
Category:   Articles > Cardiology


3. Monitoring and Managing Cardiotoxicities Associated with Cancer Therapies: An Expert Interview with
  In this interview, Dr. Douglas discusses some of the key challenges facing oncologists today in monitoring and managing cardiotoxicities associated with cancer therapeutics.
NCCN Clinical Practice Oncology Forum
Category:   Articles > Cardiology


4. Aliskiren Reduces LVH to Same Extent as Losartan
  A combination of the new direct renin inhibitor aliskiren and losartan is no more effective than either drug alone in reducing left ventricular hypertrophy. Nevertheless, the results show that the two drugs are equivalent in this regard, providing the first solid data that aliskiren can reduce LV mass and adding to the body of knowledge about the new drug, says the lead investigator. Heartwire
Category:   Articles > Cardiology


5. ASN 2007: Emerging Therapies for Management of Mineral Bone Disorders in Chronic Kidney Disease
  Mineral bone disorder and vascular calcification are major risk factors for CVD morbidity and mortality in patients with CKD. Emerging data on the role of vitamin D analogues are reported. Medscape Nephrology
Category:   Articles > Cardiology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS